CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 9 enrolled
Drug / intervention
Blue Light Box 467 nm +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00269633
NCT00269633Phase 2Completed
CompareCT.gov

Optimizing Light Wavelength for Treatment of Seasonal Affective Disorder

Thomas Jefferson University·interventional·Posted Dec 23, 2005·Updated Mar 28, 2016

In Brief

A Phase 2 clinical trial evaluating Blue Light Box 467 nm and Red Light Box 657 nm for Seasonal Affective Disorder. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The specific aim of this study is to test the hypothesis that light stimuli concentrated around 467 nm will evoke a significantly stronger therapeutic response in SAD patients compared to light stimuli concentrated around 657 nm at an equal photon density. The secondary objective of this study is to determine the efficacy of different colors and levels of light in order to optimize therapeutic benefit, while also minimizing side effects and maintaining safety of light exposure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeasonal Affective Disorder
CountriesUnited States
CollaboratorsApollo Health Systems

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 23, 2005
Enrollment StartNov 1, 2006
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 20.5 years ago

Interventions

Blue Light Box 467 nmdevice

467 nm Blue LED Light

Red Light Box 657 nmdevice

657 nm Red LED Light